SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: DanZ who wrote (3895)8/4/2001 5:03:15 PM
From: Hank  Respond to of 5582
 
"According to the Wisconsin researcher, however, more research on Zicam is needed, because ``there are a number of questions about the analysis and methodology of the study.''"
Really?? To think the study was done by a highly "respected" Harvard MD who, in spite of his compensation for producing the "study", did his his very best to insure that the study was scientifically "unbiased"!

It was even published in the highly respected journal ENT!!!!!

Say it ain't so Danny Boy!!!!!


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News